Latest Articles and Analysis

Feb 2, 20255 min read

HIV/HCV Co-Infection Watch Q1: January 2025

Q1 2025 Watch: comprehensive update on HIV/HCV co-infection treatment access across federal and state programs.

Jan 27, 202525 min read

Storm clouds gather over the Capitol as lawmakers face critical healthcare decisions in the final days of the lame duck session.

Healthcare in the Lame Duck

Healthcare policy opportunities and threats during lame duck congressional session.

Dec 8, 202410 min read

A close-up photograph with a blue tint showing a medical document about Hepatitis C. The words "Hepatitis C" are printed in large, bold black letters across the center. A pair of metal-rimmed reading glasses rests on the paper above the main heading.

Bipartisan Hepatitis C Elimination Plan Presents Critical Lame Duck Opportunity

Bipartisan HCV elimination legislation analysis and critical legislative window.

Nov 17, 20246 min read

A dramatic 3D digital rendering of a caduceus medical symbol split vertically down the middle on a cracked gray wall. The left side is smooth white stone glowing with a bright pink neon light behind it, while the right side is made of fractured, dark textured charcoal stone glowing with a subtle blue and red neon light.

Partisan Battles Put Public Health Programs in Jeopardy

Partisan political battles threaten essential public health programs and HIV funding.

Nov 10, 20247 min read

HIV/HCV Co-Infection Watch Q4: October 2024

Q4 2024 Watch: HCV treatment access assessment with guidance for disaster-displaced individuals.

Ranier Simons

Oct 27, 202424 min read

HIV/HCV Co-Infection Watch Q2: April 2024

Q2 2024 Watch: Prior authorization rollbacks in Medicaid HCV programs; ADAP and assistance program coverage.

Ranier Simons

Apr 28, 202424 min read

HIV/HCV Co-Infection Watch Q1: January 2024

Q1 2024 Watch: Pandemic Medicaid protections ended; millions lost coverage; ADAP and veterans updates.

Ranier Simons

Jan 29, 202422 min read

Upholding Our Ethical, Moral, and Bipartisan Commitment to HIV/AIDS

Proposed $767M HIV cuts betray bipartisan legacy; RWHAP and PEPFAR face critical funding threats.

Dec 10, 20235 min read

HIV/HCV Co-Infection Watch Q4: October 2023

Q4 2023 Watch: Bipartisan PEPFAR reauthorization push; ADAP coverage and Medicaid updates tracked.

Oct 29, 202327 min read

Feds: "Harm Reduction Framework"

SAMHSA releases Harm Reduction Framework for federal substance use programming and community approaches.

Jul 30, 20233 min read

HIV/HCV Co-Infection Watch Q3: July 2023

Q3 2023 Watch: HIV disparities coverage; debt ceiling crisis impacts; Medicaid disenrollment trends tracked.

Jul 25, 202327 min read

House Appropriations Mark-Up Alarms HIV Advocates

House appropriations proposes deep cuts to HIV/HCV funding including elimination of EHE initiative.

Jul 23, 20233 min read

HIV/HCV Co-Infection Watch Q2: April 2023

Q2 2023 Watch: Braidwood decision impacts PrEP coverage; ADAP coverage analysis and Medicaid program updates.

Apr 23, 202325 min read

New STI Surveillance Report – It's Not Good

STI surveillance report shows rising syphilis and congenital syphilis amid workforce shortages.

Apr 16, 20233 min read

Analysis: Biden's Budget Request Emphasizes HIV, HCV Goals

Biden FY2024 budget includes $9.7B PrEP program and $11B Hepatitis Elimination Program.

Mar 26, 20235 min read

HIV/HCV Co-Infection Watch Q1: January 2023

Q1 2023 Watch: Tennessee rejecting federal HIV funding; updates on ADAPs, Medicaid, veterans care, and harm reduction.

Jan 29, 202327 min read

HIV/HCV Co-Infection Watch Q4: October 2022

Q4 2022 Watch: HHS renewed opioid emergency; CANN launched monkeypox project; HEPLISAV-B hepatitis B vaccine covered.

Oct 24, 202225 min read

Feds Launch National HIV/AIDS Strategy Implementation Plan

White House releases federal implementation plan with 380+ action items for National HIV/AIDS Strategy.

Sep 4, 20223 min read

Jen's Half Cents: Industry Investment in Advocacy Must Look Beyond the Next Quarter

Sustainable advocacy requires long-term investment beyond quarterly financial commitments.